4bla
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='4bla' size='340' side='right'caption='[[4bla]], [[Resolution|resolution]] 3.50Å' scene=''> | <StructureSection load='4bla' size='340' side='right'caption='[[4bla]], [[Resolution|resolution]] 3.50Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4bla]] is a 4 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4bla]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4BLA OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4BLA FirstGlance]. <br> |
| - | </td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4bl8|4bl8]], [[4bl9|4bl9]], [[4blb|4blb]], [[4bld|4bld]]</td></tr> | + | </td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[4bl8|4bl8]], [[4bl9|4bl9]], [[4blb|4blb]], [[4bld|4bld]]</div></td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4bla FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4bla OCA], [https://pdbe.org/4bla PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4bla RCSB], [https://www.ebi.ac.uk/pdbsum/4bla PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4bla ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [[ | + | [[https://www.uniprot.org/uniprot/MALE_ECOLI MALE_ECOLI]] Involved in the high-affinity maltose membrane transport system MalEFGK. Initial receptor for the active transport of and chemotaxis toward maltooligosaccharides. |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Revision as of 07:17, 31 August 2022
Crystal structure of full-length human Suppressor of fused (SUFU) mutant lacking a regulatory subdomain (crystal form II)
| |||||||||||
